Recommended Screening and Preventive Practices for Long-Term Survivors after Hematopoietic Cell Transplantation

Navneet S. Majhail, J. Douglas Rizzo, Stephanie J. Lee, Mahmoud Aljurf, Yoshiko Atsuta, Carmem Bonfim, Linda J. Burns, Naeem Chaudhri, Stella Davies, Shinichiro Okamoto, Adriana Seber, Gerard Socie, Jeff Szer, Maria Teresa van Lint, John R. Wingard, Andre Tichelli

Research output: Contribution to journalArticle

160 Citations (Scopus)

Abstract

Advances in hematopoietic cell transplantation (HCT) technology and supportive care techniques have led to improvements in long-term survival after HCT. Emerging indications for transplantation, introduction of newer graft sources (eg, umbilical cord blood) and transplantation of older patients using less intense conditioning regimens have also contributed to an increase in the number of HCT survivors. These survivors are at risk for developing late complications secondary to pre-, peri-, and posttransplantation exposures and risk factors. Guidelines for screening and preventive practices for HCT survivors were published in 2006. An international group of transplantation experts was convened in 2011 to review contemporary literature and update the recommendations while considering the changing practice of transplantation and international applicability of these guidelines. This review provides the updated recommendations for screening and preventive practices for pediatric and adult survivors of autologous and allogeneic HCT.

Original languageEnglish
Pages (from-to)348-371
Number of pages24
JournalBiology of Blood and Marrow Transplantation
Volume18
Issue number3
DOIs
Publication statusPublished - 2012 Mar

Fingerprint

Cell Transplantation
Survivors
Transplantation
Guidelines
Fetal Blood
Pediatrics
Technology
Transplants
Survival

Keywords

  • Allogeneic
  • Autologous
  • Hematopoietic cell transplantation
  • Late complications
  • Prevention
  • Screening

ASJC Scopus subject areas

  • Transplantation
  • Hematology

Cite this

Recommended Screening and Preventive Practices for Long-Term Survivors after Hematopoietic Cell Transplantation. / Majhail, Navneet S.; Rizzo, J. Douglas; Lee, Stephanie J.; Aljurf, Mahmoud; Atsuta, Yoshiko; Bonfim, Carmem; Burns, Linda J.; Chaudhri, Naeem; Davies, Stella; Okamoto, Shinichiro; Seber, Adriana; Socie, Gerard; Szer, Jeff; van Lint, Maria Teresa; Wingard, John R.; Tichelli, Andre.

In: Biology of Blood and Marrow Transplantation, Vol. 18, No. 3, 03.2012, p. 348-371.

Research output: Contribution to journalArticle

Majhail, NS, Rizzo, JD, Lee, SJ, Aljurf, M, Atsuta, Y, Bonfim, C, Burns, LJ, Chaudhri, N, Davies, S, Okamoto, S, Seber, A, Socie, G, Szer, J, van Lint, MT, Wingard, JR & Tichelli, A 2012, 'Recommended Screening and Preventive Practices for Long-Term Survivors after Hematopoietic Cell Transplantation', Biology of Blood and Marrow Transplantation, vol. 18, no. 3, pp. 348-371. https://doi.org/10.1016/j.bbmt.2011.12.519
Majhail, Navneet S. ; Rizzo, J. Douglas ; Lee, Stephanie J. ; Aljurf, Mahmoud ; Atsuta, Yoshiko ; Bonfim, Carmem ; Burns, Linda J. ; Chaudhri, Naeem ; Davies, Stella ; Okamoto, Shinichiro ; Seber, Adriana ; Socie, Gerard ; Szer, Jeff ; van Lint, Maria Teresa ; Wingard, John R. ; Tichelli, Andre. / Recommended Screening and Preventive Practices for Long-Term Survivors after Hematopoietic Cell Transplantation. In: Biology of Blood and Marrow Transplantation. 2012 ; Vol. 18, No. 3. pp. 348-371.
@article{38bd4c01939c4d0494b2002b0f920c50,
title = "Recommended Screening and Preventive Practices for Long-Term Survivors after Hematopoietic Cell Transplantation",
abstract = "Advances in hematopoietic cell transplantation (HCT) technology and supportive care techniques have led to improvements in long-term survival after HCT. Emerging indications for transplantation, introduction of newer graft sources (eg, umbilical cord blood) and transplantation of older patients using less intense conditioning regimens have also contributed to an increase in the number of HCT survivors. These survivors are at risk for developing late complications secondary to pre-, peri-, and posttransplantation exposures and risk factors. Guidelines for screening and preventive practices for HCT survivors were published in 2006. An international group of transplantation experts was convened in 2011 to review contemporary literature and update the recommendations while considering the changing practice of transplantation and international applicability of these guidelines. This review provides the updated recommendations for screening and preventive practices for pediatric and adult survivors of autologous and allogeneic HCT.",
keywords = "Allogeneic, Autologous, Hematopoietic cell transplantation, Late complications, Prevention, Screening",
author = "Majhail, {Navneet S.} and Rizzo, {J. Douglas} and Lee, {Stephanie J.} and Mahmoud Aljurf and Yoshiko Atsuta and Carmem Bonfim and Burns, {Linda J.} and Naeem Chaudhri and Stella Davies and Shinichiro Okamoto and Adriana Seber and Gerard Socie and Jeff Szer and {van Lint}, {Maria Teresa} and Wingard, {John R.} and Andre Tichelli",
year = "2012",
month = "3",
doi = "10.1016/j.bbmt.2011.12.519",
language = "English",
volume = "18",
pages = "348--371",
journal = "Biology of Blood and Marrow Transplantation",
issn = "1083-8791",
publisher = "Elsevier Inc.",
number = "3",

}

TY - JOUR

T1 - Recommended Screening and Preventive Practices for Long-Term Survivors after Hematopoietic Cell Transplantation

AU - Majhail, Navneet S.

AU - Rizzo, J. Douglas

AU - Lee, Stephanie J.

AU - Aljurf, Mahmoud

AU - Atsuta, Yoshiko

AU - Bonfim, Carmem

AU - Burns, Linda J.

AU - Chaudhri, Naeem

AU - Davies, Stella

AU - Okamoto, Shinichiro

AU - Seber, Adriana

AU - Socie, Gerard

AU - Szer, Jeff

AU - van Lint, Maria Teresa

AU - Wingard, John R.

AU - Tichelli, Andre

PY - 2012/3

Y1 - 2012/3

N2 - Advances in hematopoietic cell transplantation (HCT) technology and supportive care techniques have led to improvements in long-term survival after HCT. Emerging indications for transplantation, introduction of newer graft sources (eg, umbilical cord blood) and transplantation of older patients using less intense conditioning regimens have also contributed to an increase in the number of HCT survivors. These survivors are at risk for developing late complications secondary to pre-, peri-, and posttransplantation exposures and risk factors. Guidelines for screening and preventive practices for HCT survivors were published in 2006. An international group of transplantation experts was convened in 2011 to review contemporary literature and update the recommendations while considering the changing practice of transplantation and international applicability of these guidelines. This review provides the updated recommendations for screening and preventive practices for pediatric and adult survivors of autologous and allogeneic HCT.

AB - Advances in hematopoietic cell transplantation (HCT) technology and supportive care techniques have led to improvements in long-term survival after HCT. Emerging indications for transplantation, introduction of newer graft sources (eg, umbilical cord blood) and transplantation of older patients using less intense conditioning regimens have also contributed to an increase in the number of HCT survivors. These survivors are at risk for developing late complications secondary to pre-, peri-, and posttransplantation exposures and risk factors. Guidelines for screening and preventive practices for HCT survivors were published in 2006. An international group of transplantation experts was convened in 2011 to review contemporary literature and update the recommendations while considering the changing practice of transplantation and international applicability of these guidelines. This review provides the updated recommendations for screening and preventive practices for pediatric and adult survivors of autologous and allogeneic HCT.

KW - Allogeneic

KW - Autologous

KW - Hematopoietic cell transplantation

KW - Late complications

KW - Prevention

KW - Screening

UR - http://www.scopus.com/inward/record.url?scp=84863012690&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84863012690&partnerID=8YFLogxK

U2 - 10.1016/j.bbmt.2011.12.519

DO - 10.1016/j.bbmt.2011.12.519

M3 - Article

VL - 18

SP - 348

EP - 371

JO - Biology of Blood and Marrow Transplantation

JF - Biology of Blood and Marrow Transplantation

SN - 1083-8791

IS - 3

ER -